Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Diomed takes EVLT (EndoVenous Laser Treatment) to broader US market:

This article was originally published in Clinica

Executive Summary

Diomed Holdings has received US 510(k) clearance to expand the market for its EndoVenous Laser Treatment (EVLT). Since January 2002, the EVLT has been sold for treating venous reflux in the great saphenous vein associated with varicose veins. The new clearance allows the firm's 810nm D15 Plus and D30 Plus laser systems and associated procedure kits to be used for treatment of venous incompetence and for reflux of other superficial veins in the lower extremity. Describing the clearance as a first"s, James Wyli, Diomed's president and CEO, said: "We view this as a further growth opportunity." Lower extremity venous insufficiency affects 20-25% of women and 10-15% of men, said the Andover, Massachusetts firm.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT060537

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel